Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 1, 2009, 9:05PM ET - U.S. Markets Closed. Dow  1.23% Nasdaq  1.46%

Reliv International, Inc. (RELV)

At 3:52PM ET: 3.24   0.32 (8.99%)

MORE ON RELV

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Industry: Drug Manufacturers - Other Get Industry for:
RELV SECTOR / INDUSTRY MEMBERSHIP Sector: Healthcare Industry: Drug Manufacturers - Other INTRADAY PERFORMANCE SUMMARY Name Ticker Change Reliv International, Inc. RELV 8.99% Drug Manufacturers - Other ^YHOh784 1.92% View Drug Manufacturers - Other Industry Center DRUG MANUFACTURERS - OTHER INDUSTRY NEWS • Dyax gets FDA approval for genetic disorder drug Tue 7:26 PM - AP • FDA approves OTC version of heartburn drug Zegerid Tue 7:12 PM - AP • Santarus shares rise on FDA drug approval Tue 5:38 PM - at MarketWatch • Santarus Announces FDA Approval of Schering-Plough HealthCare Products' ZEGERID OTC Tue 5:20 PM - Business Wire • Alexion Appoints William R. Keller to its Board of Directors Tue 4:30 PM - Business Wire More Industry News... TOP DRUG MANUFACTURERS - OTHER COMPANIES BY MARKET CAP Company Symbol Price Change Market Cap P/E Teva Pharmaceutical Industries Limited TEVA 53.38 1.12% 47.03B 48.84 Novo Nordisk A/S NVO 69.09 3.55% 41.21B 19.46 Allergan Inc. AGN 58.90 1.32% 17.90B 31.98 Forest Laboratories Inc. FRX 31.01 1.14% 9.36B 12.85 Vertex Pharmaceuticals Incorporated VRTX 39.86 2.68% 7.22B N/A Reliv International, Inc. RELV 3.24 8.99% 39.63M 21.74 Showing 1 - 5 of 73 - View All More Top Companies: by Performance, by Valuation, by Growth, more... RELV VS. INDUSTRY LEADERS Statistic Industry Leader RELV RELV Rank Market Capitalization TEVA 47.03B 39.63M 58 / 73 P/E Ratio (ttm) CPIX 60.87 21.74 5 / 73 PEG Ratio (ttm, 5 yr expected) SCR 2.27 1.01 13 / 73 Revenue Growth (Qtrly YoY) ACCP.OB 206.40% -12.50% 41 / 73 EPS Growth (Qtrly YoY) WCRX 955.10% -26.80% 17 / 73 Long-Term Growth Rate (5 yr) PTIE 83.8% 20.4% 20 / 73 Return on Equity (ttm) CBST 65.94% 13.76% 10 / 73 Long-Term Debt/Equity (mrq) N/A Dividend Yield (annual) TPI 3.00% 1.10% 3 / 73 View Leaders & Laggards MORE ON DRUG MANUFACTURERS - OTHER • Industry Summary • News • Leaders & Laggards • Company List • Industry Calendar RELATED INDUSTRIES • Biotechnology • Diagnostic Substances • Drug Delivery • Drug Manufacturers - Major • Drug Related Products • Drugs - Generic Top Performing Industries | Complete Industry List
Add to Portfolio     Set Alert     Email to a Friend Get Industry for Another Symbol: Symbol Lookup • Research Reports Screener • Industry Center